Meaning
A contractual provision in a loan agreement allows a borrower’s shareholders to inject new capital to remedy a financial covenant violation. This process, known as an equity cure, treats the cash injection as additional earnings for the purpose of recalculating the compliance ratios. It prevents an immediate default by restoring the financial metrics to their required levels.
Funding Mechanism
The new funds must be provided as common equity or qualified preferred equity to avoid adding to the company’s debt burden. This cash is then added to EBITDA for the specific period being tested, which artificially inflates the earnings figure. This adjustment is only used for compliance testing and does not change the actual operating results.
Leverage Correction
The injection of equity brings the leverage ratio back within permitted bounds. By increasing the denominator of the ratio, the company can show compliance even if its actual operational earnings fell short.
Contractual Limit
Lenders restrict the frequency and total number of times this remedy can be used. Typical agreements permit the cure to be exercised no more than two times in any four-quarter period and no more than four times over the life of the loan. This ensures that the equity cure cannot be used to indefinitely mask a structurally failing business model.